We used Ki67 as a marker for proliferation (Fig. 4b,d) to distinguish actively proliferating from quiescent cells and carbonic anhydrase 9 (CA IX, Fig. 4b, Supplementary Fig. 4b) as a hypoxia marker associated with poor prognosis in CRC patients31. Here, CA9 is linked to colorectal carcinoma.